Navigation Links
Anaphore Enters R&D Partnership with Mitsubishi Tanabe Pharma to Develop and Commercialize Novel Protein Pharmaceuticals for Autoimmune Disorders
Date:12/13/2010

and Anaphore will commence the research and development alliance immediately.

"This agreement exemplifies Anaphore's plan to form partnerships while exploring the potential of Atrimers to improve therapy in a wide range of diseases," said Katherine Bowdish, Ph.D., Anaphore's Chief Executive Officer. "In Mitsubishi Tanabe Pharma, we have a partner with a record of success in the biologics market and a commitment to advancing a new class of protein therapeutics for immune-system disorders."

Initial research activities will be conducted by TRL and Anaphore. Mitsubishi Tanabe Pharma will be responsible for late stage development and worldwide commercialization following the selection of lead candidates.

About Mitsubishi TanabePharma and Tanabe Research Laboratories U.S.A.,Inc. (TRL)Mitsubishi Tanabe Pharma Corporation is a research-driven pharmaceutical company based in Japan, specializing in research, development and marketing of globally competitive pharmaceutical products focused on the immune and inflammatory field, and the metabolism and cardiovascular field.  Mitsubishi Tanabe Pharma contributes to the healthier lives of people around the world through the creation of pharmaceuticals.

http://www.mt-pharma.co.jp/e

TRL is an independent subsidiary of Mitsubishi Tanabe Pharma Corporation whose role is to discover and develop potential biological drug candidates for therapy in autoimmune diseases.

Currently, TRL's efforts will be directed towards antibody and antibody related research to target specific immune cells and soluble factors, as well as investigating new methods for modulating immune cell functions. TRL will establish collaborative relationships with other companies and academic research organizations to further its goals of identifying lead preclinical compounds for further development and to consolidate its presence in
'/>"/>

SOURCE Anaphore Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tanabe Research Labs Enters R&D Partnership with Anaphore to Develop Novel Protein Pharmaceuticals for Autoimmune Disorders
2. Cancer Treatment Centers Oncology Information System Options Expand with New MOSAIQ Connectivity
3. NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
4. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
5. Seven U.S. Medical Centers Commence Study to Change Femoral Artery Cath Lab Access with the First Alternative to the Seldinger Technique in 51 Years
6. Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited
7. CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers
8. Merlot OrthopediX Enters into Exclusive Global Agreement with Alphatec Spine to Develop and Market Merlots Bone Anchorage Technology for the Treatment of Spine Disorders
9. HealthSport Enters Letter of Intent With CURE Pharmaceutical for Joint Development of Unique Pediatric Malaria Drug Product and Other Healthcare Related Products
10. Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil
11. Fenwal Named Exclusive Provider of AccuVeins Award-Winning Vein Illumination Device for Blood and Plasma Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , January 15, 2014 BreedIT Corp ... exclusive worldwide distributor of highly sophisticated agro-breeding solutions for ... 7, 2014, the Company,s board of directors appointed chemistry ... as its new member of the board. ...
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB ... composition of matter, biological targets, mechanism of action, methods ... This patent application describes a novel class ... which interfere with the basic homeostatic cellular processes in ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... Forecast – Worldwide Analysis ... Market Analysis Insulin ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... July 12 Endo Pharmaceuticals (Nasdaq: ENDP ) today ... offer by its wholly owned subsidiary, HT Acquisition Corp., for all ... HTRN).  American Stock Transfer & Trust Company, the depositary for the ... , New York City time, on July 9, ...
... 12 Signum Biosciences announced that its ... Medirepair® with Signum,s compound Arazine™ (n-acetyl-s-farnsylcysteine or AFC) ... compound from Signum,s novel anti-inflammatory platform to be ... (STMs). The DRx AFC Medirepair® website can be ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 2Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 3Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 4Signum Biosciences, Inc. Announces Commercial Launch of Arazine™ 2Signum Biosciences, Inc. Announces Commercial Launch of Arazine™ 3
(Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
(Date:4/17/2014)... estimated that as many as 10 million older Americans ... loneliness and isolation. , However, new research a ... older Americans for six years found that Internet ... depression by more than 30 percent. , "That,s a ... University professor of telecommunication, information studies and media who ...
(Date:4/17/2014)... a new mechanism that allows blood to enter the ... and the Salk Institute have opened the door to ... damage. , A complex and devastating neurological condition, stroke ... for disability in the U.S. The blood-brain barrier is ... into the brain, causing the permanent deficits in movement ...
(Date:4/17/2014)... Calif.) An international team led by researchers at ... complex, which plays a key role in cell division, ... This is the first time the complex has been ... make cyclin B1/Cdk1 an excellent target to control cellular ... The research was published online today in the journal ...
(Date:4/17/2014)... Population Council scientists and their partners have found that ... prevent the transmission of multiple sexually transmitted infections (STIs) ... herpes simplex virus 2 (HSV-2), and human papillomavirus (HPV). ... the gel is effective against multiple strains of HIV, ... against all three viruses of at least eight hours ...
Breaking Medicine News(10 mins):Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... National Dementia Screening Policy , , ... the nation faces a public health crisis related to ... the Alzheimer,s Foundation of America (AFA) disputes an ongoing ... The report shatters unsubstantiated criticism and instead emphasizes the ...
... Non-Contact Medical Device Innovations - the Future of Patient ... in Outer Space , , ... Noninvasive Medical Technologies, Inc. (NMT), a medical device company ... for military and civilian medical use, today announced that ...
... /PRNewswire-Asia-FirstCall/ -- China Shenghuo,Pharmaceutical Holdings, Inc. (NYSE Alternext ... that the Company is expanding its herbal-based,"12 Ways" ... markets in Mainland China. , ... its "12 Ways" brand of cosmetics products,to eleven ...
... PatentStorm, the searchable website of millions of U.S. patents, has expanded ... applications. PatentStorm has also completed a host of other improvements, making ... ... Washington, DC (PRWEB) December 9, 2008 -- PatentStorm ...
... China, Dec. 9 /PRNewswire-Asia-FirstCall/ -- China Sky One ... (Nasdaq: CSKI ), a leading,fully integrated ... of China ("PRC"), announced today that its subsidiary,Peng ... production approval from the State Food and Drug ...
... for Low-dose, Weekly Contraceptive Patch to be Presented at ACOG ... , PRINCETON, N.J., Dec. 9 Agile ... products, today announced that two abstracts from Phase 2 studies ... by the American College of Obstetricians and Gynecologists Annual ...
Cached Medicine News:Health News:New Study Disputes Ongoing Controversy Over Memory Screenings 2Health News:New Study Disputes Ongoing Controversy Over Memory Screenings 3Health News:New Study Disputes Ongoing Controversy Over Memory Screenings 4Health News:U.S. Air Force Awards Noninvasive Medical Technologies $2.4 Million Contract 2Health News:U.S. Air Force Awards Noninvasive Medical Technologies $2.4 Million Contract 3Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 2Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 3Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 4Health News:PatentStorm Releases U.S. Patent Applications and Other Features 2Health News:China Sky One Medical, Inc. Obtains Production Rights for Two New Drugs 2Health News:China Sky One Medical, Inc. Obtains Production Rights for Two New Drugs 3Health News:Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG 2Health News:Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG 3Health News:Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG 4
... a simple click of the mouse ... mouse cursor to the desired position ... slide and the magnified image is ... Interface (GUI) enables one-click operation of ...
... new Eclipse TS100 is an ... microscope. This high quality tool ... mechanics and increased stability - ... rigid vibration resistant design that ...
Carbide drill bits, cutters, side cutting. Available in various sizes....
... the enclosed polaroid glasses, these polarized ... devise for near point stereopsis which ... perception, the images appear to pop ... test includes circle patterns for depth ...
Medicine Products: